ABSORBABLE - Medipac | PTFE sutures | ptfe membranes | surgical sutures | Th.Kazantzidis S.A | Kilkis | Greece

Go to content

Main menu:

PGA
PGA-Polyglycolic Acid Synthetic Absorbable Surgical Suture is indicated for use in general soft tissue approximation and/or ligation, including use in ophthalmic procedures, but not for use in cardiovascular and neurological procedures. PGA suture elicits a minimal acute inflammatory reaction in tissues, which is followed by gradual encapsulation of the suture by fibrous connective tissue.

Progressive loss of tensile strength and eventual absorption of Polyglycolic Acid Synthetic Absorbable Sutures occurs hydrolysis, where the polymer degrades to glycolic acid which is subsequently absorbed and metabolized by the body. Absorption begins as a loss of tensile strength without appreciable loss of mass. Polyglycolic Acid Synthetic Absorbable Suture PGA retains approximately 75% of the average E.P. tensile strength requirement at the end of the 2nd post implantation week, and more than 35% at the end of the 3rd week. The absorption of the suture is essentially complete between 50 and 90 days.

See more...

NEOSORB (PGLA)
NEOSORB PGLA Synthetic Absorbable Surgical Suture is indicated for use in general soft tissue approximation and/or ligation, including use in ophthalmic procedures, but not for use in cardiovascular and neurological procedures. NEOSORB PGLA Synthetic Absorbable Surgical Suture elicits a minimal acute inflammatory reaction in tissues, which is followed by gradual encapsulation of the suture by fibrous connective tissue.

Progressive loss of tensile strength and eventual absorption of NEOSORB PGLA Synthetic Absorbable Sutures occurs hydrolysis, where the polymer degrades to glycolic and lactic acids which are subsequently absorbed and metabolized in the body. Absorption begins as a loss of tensile strength without appreciable loss of mass. NEOSORB PGLA retains approximately 50% of the average E.P. tensile strength requirement at the end of the 3nd post implantation week. The absorption of the suture is essentially complete between 56-70 days.

See more...

NEOSORB RAPID (RPGLA)

NEOSORB RAPID Synthetic Absorbable Surgical Suture is indicated only for use in soft tissue approximation of the skin and mucosa, plastic surgery, where only short-term wound support is required. It is not indicated for use in ligation, ophthalmic, cardiovascular, or neurological procedures. NEOSORB RAPID Synthetic Absorbable Surgical Suture elicits a minimal acute inflammatory reaction in tissues,

which is followed by gradual encapsulation of the suture by fibrous connective tissue. Progressive loss of tensile strength and eventual absorption of NEOSORB RAPID Synthetic Absorbable Sutures occurs hydrolysis, where the polymer degrades to glycolic and lactic acids which are subsequently absorbed and metabolized in the body. NEOSORB RAPID retains approximately 50% of the original tensile strength at 5 days post implantation. All of the original tensile strength is lost by approximately 10 to 14 days. Absorption is essentially complete by 42 days.

See more...

MONOSORB
Monosorb monofilament synthetic absorbable surgical sutures are used for general soft tissue approximation and/or ligation ,even in microsurgery and ophthalmic surgery.But not for use in cardiovascular tissues and tissues of the central nervous system. The implantation of the MONOSORB monofilament synthetic absorbable surgical suture elicits a minimal inflammatory reaction which is followed by the development of fibrous connective tissue in place.

Progressive loss of tensile strength and eventual absorption of the suture occurs by means of hydrolysis, where the polymer degrades to carbon dioxide and water which is subsequently absorbed and metabolized by the tissues. Absorption begins as a loss of tensile strength without appreciable loss of mass. The retention of the MONOSORB absorbable suture is 65-70% of the original tensile strength after 4 weeks and 50-60% after 6 weeks. The absorption of the suture is essentially completed after a period of 180-220 days.

See more...

MONOFAST
Monofast monofi lament synthetic absorbable surgical suture is indicated for use in general soft tissue approximation and/or ligation, but not for use in cardiovascular tissues and tissues of the central nervous system and also in microsurgery and ophthalmic surgery. The implantation of the MONOFAST monofilament synthetic absorbable surgical suture elicits a minimal infl ammatory reaction which is followed by the development of fi brous connective tissue in place. Progressive loss of tensile strength and eventual absorption of the suture occurs

by means of hydrolysis, where the polymer degrades to adipic acid which is subsequently absorbed and metabolized by the tissues. Absorption begins as a loss of tensile strength without appreciable loss of mass. The retention of the MONOFAST suture is 68-78% of the original tensile strength after the 1st week and approximately 30% after the end of the 2nd week. The absorption of the suture is essentially completed after a period of 90- 110 days. Its original tensile strength is essentially lost 28 days after its implantation.

See more...

 
Back to content | Back to main menu